Cargando…
CASP4 can be a diagnostic biomarker and correlated with immune infiltrates in gliomas
BACKGROUND: Gliomas are the most common and invasive malignant tumors that originate in the central nervous system. Currently, the primary treatment modality for gliomas is maximum surgical resection, supplemented by radiotherapy and chemotherapy. However, the long-term survival rate has not signifi...
Autores principales: | Tian, Guopeng, Li, Qiao, Niu, Liang, Luo, Yusong, Wang, Hongyu, Kang, Wei, Fang, Xiang, Bai, Shengwei, Yuan, Guoqiang, Pan, Yawen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874090/ https://www.ncbi.nlm.nih.gov/pubmed/36713560 http://dx.doi.org/10.3389/fonc.2022.1025065 |
Ejemplares similares
-
Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities
por: Luo, Yusong, et al.
Publicado: (2022) -
CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022) -
Intracerebral hemorrhage associated with brucellosis: A case report
por: Luo, Yusong, et al.
Publicado: (2022) -
EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis
por: Wu, Yuxi, et al.
Publicado: (2023) -
LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)